Washington State University, Spokane, WA, USA.
Am J Manag Care. 2010 Oct 1;16(10):e245-50.
To determine the accuracy of patients' electronic medical record (EMR) drug profiles, to assess the relationship of copayment status with errors of commission and omission within drug profiles, and to evaluate the association between errors of commission in primary and secondary sections of the drug profiles.
Cross-sectional analysis of patients' EMR drug profiles at a 46-bed hospital in Washington state.
Patients' drug profiles were compared against hospital staff interviews. Drug profiles listing each medication the patient was taking, without listing drugs the patient was not taking, exhibited perfect accuracy. We evaluated associations between errors of commission and omission, copayment status between errors of commission and omission, and associations between errors of commission in primary and secondary sections of the drug profiles.
Demographics of study patients are similar to previously published research, and accuracy outcomes seem to be better than those of previously published studies. Fifty-six percent of drug profiles in our study hospital exhibited perfect accuracy. Errors of commission and omission were unassociated with copayment status; errors of commission in the primary section of the drug profile were unassociated with errors of commission in the secondary section of the drug profile.
A medication reconciliation program may have led to a high rate of perfectly accurate drug profiles; while its purpose is to increase accuracy and to decrease errors, it may also assist in reducing adverse drug events. Results show that copayment amounts influence drug utilization; these may be associated with errors of commission and omission and not simply with copayment status.
确定患者电子病历（EMR）药物概况的准确性，评估共付状况与药物概况中用药错误的关系，并评估药物概况主次两部分用药错误之间的关联。
华盛顿州一家 46 床医院的患者 EMR 药物概况的横断面分析。
将患者的药物概况与医院工作人员访谈进行比较。列出患者正在服用的每种药物而未列出患者未服用的药物的药物概况显示出完美的准确性。我们评估了用药错误和遗漏之间的关联、共付状况与用药错误和遗漏之间的关联，以及药物概况主次两部分用药错误之间的关联。
研究患者的人口统计学特征与之前发表的研究相似，且准确性结果似乎优于之前发表的研究。我们研究医院的 56%的药物概况显示出完美的准确性。用药错误和遗漏与共付状况无关；药物概况主要部分的用药错误与药物概况次要部分的用药错误无关。
药物重整计划可能导致了高比例的完全准确的药物概况；虽然其目的是提高准确性并减少错误，但它也可能有助于减少药物不良事件。结果表明，共付金额影响药物利用；这些可能与用药错误有关，而不仅仅与共付状况有关。
